As of July 1, 2021, Dr. Schär will divest its Metabolic Nutrition unit in order to further concentrate on customer segments with special nutritional needs as well as gluten free nutrition. The company is thus parting with the brands Mevalia and Comidamed and its products for the treatment of inborn errors of metabolism. Both brands, as well as the manufacturing facility in Rosbach, Germany, will be acquired by Vitaflo Limited, a business unit of Nestlé Health Science.
“In our medium to long-term outlook, we lay an emphasis on our nutrition-related brands. Accordingly, we are developing our global brand portfolio around Schär, Flavis and Kanso, with the aim of specialising even further in inclusive nutrition and gluten-free products - our future is in innovating special nutrition," explains Philipp Schoeller, CEO of Dr. Schär AG. With the integration of the business within Vitaflo, we are positive that they will continue our successful journey in Metabolic Nutrition. Dr. Schär's Metabolic Nutrition unit looks back on a positive business development. The devision has been able to grow profitably in recent years achieving a strong international position. This is particularly important to us, as we at Dr. Schär have been following the vision of improving the lives of people with special nutritional needs for almost 100 years. Nestlé Health Science shares our passion for health and well-being.”